Marwa Hassan | Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Marwa Hassan | Molecular Biology | Best Researcher Award

Theodor Bilharz Research Institute | Egypt

Marwa Hassan is an immunologist with substantive contributions in stem cell biology, molecular immunology, and translational research. She also holds a Postgraduate Diploma in Healthcare & Hospital Management (American University in Cairo, 2020). Over her career she has held roles from resident researcher to acting head of department at the Immunology Division of TBRI, and has organized and led numerous specialized training courses (e.g. stem cell culture, molecular immunology, ELISA). Her research interests include non-coding RNAs, stem cell differentiation, immune regulation in liver disease, and biomarker development. She has published in peer-reviewed journals (e.g. on circulating liver cancer stem cells) and contributed to capacity building via workshops and academic leadership. Her awards and recognitions reflect her dual strengths in research and academic service. In sum, Dr. Hassan combines rigorous scientific inquiry with institutional leadership, advancing immunology and regenerative medicine in Egypt and beyond.

Profile : Orcid

Featured Publications

Ahmed, M. H. M., & Abdel Hamid, H. M. (2022). Circulating liver cancer stem cells: Clinical implications and future perspectives. World Journal of Gastroenterology, 28(1), 39–52

Ahmed, M. H. M., El Refai, S., & El-Shenawy, R. (2021). MicroRNA-based biomarkers in hepatitis C virus-induced hepatocellular carcinoma. Egyptian Journal of Immunology, 28(2), 75–90.

Ahmed, M. H. M., Hussein, M., & El Sayed, A. (2020). Impact of mesenchymal stem cell passaging on proliferation and differentiation potential. Theodor Bilharz Medical Journal, 18(4), 201–210.

Ahmed, M. H. M., Ibrahim, N., & Khalifa, M. (2019). Role of regulatory T-cells in autoimmune liver diseases: An immunopathological study. Journal of Clinical and Experimental Hepatology, 9(3), 355–362.

Ahmed, M. H. M., & El Demerdash, R. (2017). Gene expression profiling of umbilical cord blood-derived mesenchymal stem cells under oxidative stress. Stem Cell Research & Therapy, 8(1), 112.

Manouchehr Fadaee | Medicine and Health Sciences | Best Researcher Award

Dr. Manouchehr Fadaee | Medicine and Health Sciences | Best Researcher Award

Tabriz University of Medical Sciences | Iran

Dr. Manouchehr Fadaee is an accomplished researcher recognized for his contributions to microbiology, immunology, cancer biology, and host–pathogen interactions.  demonstrating consistent productivity and influence in the field. His academic journey is rooted in biomedical sciences, where he advanced his expertise in immunotherapy, cancer progression, gut microbiome, infectious diseases, and exosome-mediated communication. Dr. Fadaee has experience collaborating with international journals, contributing impactful reviews and original research articles in leading platforms such as Journal of Drug Targeting, Cancer Cell International, Cell Communication and Signaling, Breast Cancer Research, and American Journal of Reproductive Immunology. His research interests span exosome-based therapies, postbiotics, gut microbiota, autoimmunity, cancer immunotherapy, and novel antimicrobial strategies. Beyond research, he has actively served as a peer reviewer for journals including Journal of Drug Targeting and Cell Biology International, enhancing the quality of scientific discourse. With several impactful works on immunotherapy and microbial interventions, Dr. Fadaee continues to advance innovative approaches to combat cancer and infectious diseases, making him a promising leader in biomedical research.

Profile : Orcid

Featured Publications

“The Cytotoxic and Immune‐Regulatory Roles of CD8+T Cell‐Derived Exosomes in Cancer: A Systematic Review”

“Gut microbiome and colorectal cancer: From pathogenesis to treatment”

“Potential of Vaginal Microbiota Transplantation (VMT) in Endometritis Management”

“Cyclophosphamide‐Induced Infertility and the Impact of Antioxidants”

“Exosome therapeutics for non-small cell lung cancer tumorigenesis”